Vijaypd Ceutical IPO
Closed SMEAlready have an account? Apply now
Vijaypd Ceutical IPO details
Schedule of Vijaypd Ceutical
| Issue open date | 29 Sep 2025 |
| Issue close date | 01 Oct 2025 |
| UPI mandate deadline | 01 Oct 2025 (5 PM) |
| Allotment finalization | 03 Oct 2025 |
| Refund initiation | 06 Oct 2025 |
| Share credit | 06 Oct 2025 |
| Listing date | 07 Oct 2025 |
| Mandate end date | 16 Oct 2025 |
| Lock-in end date for anchor investors (50%) | 02 Nov 2025 |
| Lock-in end date for anchor investors (remaining) | 01 Jan 2026 |
Note: The schedule is tentative. The anchor lock-in period ends 30 days after the actual allotment date for 50% of the shares and 90 days after for the remaining portion. The allotment status can be checked on the registrar's website and the exchange website.
About Vijaypd Ceutical
Vijaypd Ceutical Ltd, a certified pharma and FMCG distributor, supplies 19,000+ SKUs to 2,100+ pharmacies and clinics across Maharashtra. With FDA, FSSAI, and BMC approvals, it ensures quality and compliance. Backed by 60+ years of promoter experience, the company now plans to expand into API and excipient manufacturing.
Financials of Vijaypd Ceutical
Issue size
| Funds Raised in the IPO | Amount |
| Overall | ₹19.25 crores |
| Fresh Issue | ₹19.25 crores |
Utilisation of proceeds
| Purpose | INR crores (%) |
| Capex for API/Chemicals plant & machinery | 10.83 (63.7%) |
| Repayment/prepayment of borrowings | 5.10 (30%) |
| General corporate purposes | 0.74 (4.3%) |
Strengths
- Strong and diverse promoter background supports stability and strategic growth.
- Robust client base with established long-term relationships enhances revenue visibility.
- Focus on a specialized segment within the industry provides operational edge.
- Established operational processes and experienced management improve efficiency.
- Track record of business growth with scalable operations in key geographies.
Risks
- High dependency on a limited number of clients may affect revenue if contracts are lost.
- Significant outstanding debt increases financial risk and could impact cash flows.
- Ongoing or potential legal and regulatory proceedings may adversely impact the business.
- Intense competition within the sector can affect pricing power and margins.
- Vulnerability to economic downturns and industry-specific regulatory changes.
Allotment Status for Vijaypd Ceutical
To check your allotment status – click here.
Subscription Figures for Vijaypd Ceutical
As per media reports (Link), the Grey Market Premium (GMP) of Vijaypd Ceutical is reported at ₹0 over the IPO price. This metric is not reliable, and to track IPO interest, it is better to check subscription numbers published by exchanges, which are considered more reliable indicators.
Subscription numbers as of 5:00 PM on October 01, 2025:
| Category | Reserved (lakhs) | Applied (lakhs) | Subscription (X times) |
|---|---|---|---|
| NII | 26.08 | 51.28 | 1.96x |
| Retail | 26.08 | 48.32 | 1.85x |
| Total | 52.16 | 74.48 | 1.42x |